Leerink Partners Rates UnitedHealth (UNH) buy, $462 Price Target

Analyst Whit Mayo keeps a buy rating and a $462 price target on UnitedHealth Group as the stock trades around $409.25, a 12.89% upside from the current price.

By EarningsIQ Research Desk · Published Jun 17, 2026, 11:01 AM EDT · Updated Jun 24, 2026, 6:01 AM EDT

Reviewed by automated data checks against the source data. How we make and check alerts

Leerink Partners rated UnitedHealth Group Incorporated ($UNH) "buy" with a $462 price target on June 17, 2026.

Since the rating, $UNH is up 1.6% after 1 week, up 6.7% after 1 month and up 1.1% to date (from the $397.08 close on Jun 17, 2026).

UNH UnitedHealth Group Incorporated

$401.43 +21.69% year to date

Daily close · Oct 16, 2026

Key Points

Leerink Partners analyst Whit Mayo reiterated a buy rating on UnitedHealth Group with a $462 price target on June 17, 2026.
Leerink Partners's $462 price target implies 12.89% upside from UnitedHealth Group Incorporated's ($UNH) current $409.25 share price.
UnitedHealth Group shares change hands around $409.25, resting below the $462 target set by Leerink Partners.
Several Wall Street firms recently updated views on UnitedHealth Group, where 25 analysts contribute to a consensus buy recommendation with a mean target of $477.04.

Get $UNH trade alerts by text

We text you when insiders, Congress or big funds trade $UNH. Free.

Not investment advice. EarningsIQ is not a registered investment adviser, and this automated UnitedHealth Group Incorporated alert may contain errors. Disclosures

Leerink Partners Retains Buy Rating and Target

On June 17, 2026, Leerink Partners analyst Whit Mayo reiterated a buy rating on UnitedHealth Group Incorporated (NYSE: UNH) while setting a price target of $462.00. The target sits above the stock's current trading spot around $409.25, pointing to room for upside as shares move through the middle of the year.

UnitedHealth Group Shares Hover Near Midpoint

UnitedHealth Group shares change hands at $409.25, trading comfortably above the 200-day moving average of $358.75 and above the 50-day moving average of $387.35. The healthcare giant has navigated a 52-week trading range spanning from a low of $255.97 up to a high of $461.62. With a forward P/E ratio of 17.6, the valuation reflects market pricing of upcoming earnings relative to the broader healthcare sector.

12-month forecast

$UNH price target

UnitedHealth Group Incorporated daily closes and this analyst's $462 target. Not advice.

Recent Insider Share Purchases

Corporate insiders added small blocks of shares to their personal holdings on June 23, 2026. Chief Accounting Officer Dennis Andrew Stankiewicz acquired 51 shares, while Optum Chief Executive Officer Patrick Hugh Conway picked up 83 shares. Additional share acquisitions came from board members and executives, including Kristen Gil picking up 8 shares, Scott Gottlieb adding 3 shares, and John Noseworthy purchasing 41 shares. These transactions reflect routine equity alignment rather than large open-market buys.

Wall Street Analyst Coverage and Price Targets

Analyst opinion remains active across major financial firms heading into autumn. On October 16, 2026, Bernstein maintained an outperform rating while adjusting its target to $500.00 from $512.00, and JP Morgan maintained an overweight rating, raising its target to $524.00 from $516.00. Earlier in October, TD Cowen maintained a hold rating with a $402.00 target, and Piper Sandler kept an overweight rating and a $504.00 target. Barclays maintained an overweight rating with a $440.00 target, and Baird kept a neutral rating with a $427.00 target. Across 25 analyst opinions, the stock holds a consensus buy recommendation with a mean price target of $477.04.

Healthcare Operations at UnitedHealth Group

UnitedHealth Group operates as a diversified healthcare company based in Eden Prairie, Minnesota. The enterprise delivers medical benefits, care management, pharmacy services, and health technology through its primary operating units: Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare. These segments serve individual consumers, employers, care providers, and government-sponsored programs across the United States and international markets.

What to Watch Next for UNH

The company is scheduled to report its next round of earnings on January 26, 2027. Investors will look to upcoming quarterly results to see if revenue growth and operating margins align with analyst expectations. Market participants should review subsequent filings for any shifts in institutional ownership or insider trading patterns.